PUMA Signs Mutaz Essa Barshim, One of the Most Successful High Jumpers of All Time
Sports company PUMA has signed Qatari athlete Mutaz Essa Barshim, one of the most successful high jumpers of all time, who will wear the company’s performance products starting at the Diamond League Meeting in Lausanne.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220826005178/en/
Sports company PUMA has signed Qatari athlete Mutaz Essa Barshim, one of the most successful high jumpers of all time, who will wear the company’s performance products starting at the Diamond League Meeting in Lausanne. (Photo: Business Wire)
With three World Championships and an Olympic Gold to his name, Barshim has already won everything there is to win in his sport. At the World Championships in Eugene this year, he successfully defended his title and showed he is still on top of his game.
“We are so happy to welcome Mutaz to our PUMA Family,” said Pascal Rolling, Head of Sports Marketing. “He is an incredibly talented athlete, and his charm and sportsmanship has done much to promote athletics across the globe.”
Famously, Barshim and Italian PUMA athlete Gianmarco Tamberi decided to share the Gold at the Olympic Games in Tokyo after jumping the same height, creating memorable moments of fairness and comradery.
Barshim’s personal best of 2.43 meters is the Asian Record and the second-highest jump of all time. At PUMA, Barshim is part of a group of world-class athletes such as 400m hurdles World Record Holder Karsten Warholm, pole vault World Record Holder Armand “Mondo” Duplantis and Jamaican sprinters Shericka Jackson and Elaine Thompson-Herah.
To watch the announcement video, please click HERE.
PUMA
PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For more than 70 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 16,000 people worldwide, and is headquartered in Herzogenaurach/Germany.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220826005178/en/
Contact information
Media Contact:
Robert-Jan Bartunek - Corporate Communications - PUMA SE - +49 9132 81 3134 – robert.bartunek@puma.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Nexo Announces Landmark Crypto Partnership with Tennis Australia for Australian Open and Summer of Tennis17.12.2025 09:00:00 CET | Press Release
Nexo, the premier digital assets platform, has entered a landmark multi-year global partnership with Tennis Australia, becoming the Official Crypto Partner of the Australian Open and the Summer of Tennis, including the United Cup, Adelaide International, Brisbane International, and Hobart International. This agreement marks the first time a digital asset company has partnered with a Grand Slam tournament, affirming Nexo’s prestige, long-term vision, and leadership at the intersection of elite sport and digital assets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216497915/en/ Antoni Trenchev, Co-founder, Nexo, noted: “The Australian Open stands at the intersection of excellence and ambition – precisely where Nexo positions itself. Our partnership reflects a shared commitment to disciplined performance and long-term thinking. We are honored to join Tennis Australia in elevating the sport while showcasing the value of int
Jerrod Chong, Yubico ’ s Chief Operating Officer, appointed as acting CEO17.12.2025 08:05:00 CET | Press Release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and the leading provider of hardware authentication security keys, today announced that Jerrod Chong, Yubico’s current Chief Operating Officer, has been appointed to serve as acting CEO. Mattias Danielsson will be stepping down from his role as CEO of Yubico. "I am very pleased that Jerrod has accepted the role of acting CEO. With his extensive experience in cybersecurity and twelve years in senior leadership at Yubico, I am confident that he will lead Yubico on a continued path of growth and he will ensure Yubico maintains and strengthens its leading position. On behalf of the board, I also want to extend our sincere thanks to Mattias Danielsson for his hard work and significant contributions to Yubico’s development as a respected leader and colleague over sixteen years. We deeply appreciate his commitment to Yubico over the years," says Patrik Tigerschiöld, Chairman of the Board. "Yubico is entering an excitin
VeritasChain Unveils VAP Architecture, New Auditability Research, and Confirms Submissions to 58 Regulators Globally17.12.2025 08:00:00 CET | Press Release
VeritasChain today unveiled its Verifiable AI Provenance Framework (VAP) architecture, published new research on verifiable audit trails, and confirmed informational submissions to 58 regulatory authorities across 43 jurisdictions. These milestones advance VeritasChain’s mission to establish a global framework for verifiable auditability in AI and algorithmic trading. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216433807/en/ Map indicates jurisdictions where regulatory outreach or informational submissions have been made as of Dec 2025. Verifiable AI Provenance Framework (VAP) VAP is a layered assurance architecture designed for independent verification of AI decision-making. It is not a single product, but a framework defining how cryptographic evidence and third-party verification interoperate across diverse systems. The architecture records decision-to-execution events as immutable audit trails, facilitating regulat
Outpost24 Secures New Investment to Scale its Exposure Management and Identity Security Solutions17.12.2025 08:00:00 CET | Press Release
Outpost24, a leader in exposure management and identity security, today announced a new investment from Vitruvian Partners to fuel its next phase of global growth. This significant new funding will accelerate innovation across the company's platform, with a focus on integrating AI capabilities to optimize how security teams identify and neutralize critical vulnerabilities. The only European vendor recognized as an overall leader in the 2025 KuppingerCole Leadership Compass Report for Attack Surface Management, Outpost24 delivers a distinct approach to cyber defence that empowers security teams to gain a complete understanding of their digital and human risk landscape. Last week, Outpost24 announced the acquisition of Infinipoint, a specialist in device identity, posture validation, and secure workforce access. The acquisition marks the company's entry into the Zero Trust Workforce Access market and lays the foundation for its identity security division, Specops, to offer a unified appr
New Published Data Confirms Nemluvio ® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 07:00:00 CET | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements observed as early as 48 hours after treatment in some patients with atopic dermatitis and prurigo nodularis.1 The findings from post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs were published in the Journal of the European Academy of Dermatology and Venereology. Nemolizumab is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signalling of IL-31.2,5,6 IL-31 is a neuroimmune cytokine that drives itch and other symptoms in both atopic dermatitis and prurigo nodularis.3,4 These new findings reinforce the critical role of IL-31 pathway inhibition in achieving rapid itch response. Atopic dermatitis and prurigo nodularis are debilitating skin conditions that significantly affect quality of life, with symptoms such as per
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom